ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Up to 10-years of follow-up data reaffirm safety profile of Mavenclad (cladribine tablets)
worldpharmanews
October 12, 2018Merck, the vibrant science and technology company, today announced the presentation of new data for MAVENCLAD? (cladribine tablets) at the 34th Congress of the European Committee for Treatment and Research In Multiple Sclerosis (ECTRIMS) in Berlin, German
Pharma Sources Insight January 2025
